Hale’s Medications & Mothers’ Milk 2027-2028

The Go-To Resource Clinicians Trust for Lactation Pharmacology 

Clinicians rely on clear, evidence-based guidance when treating breastfeeding mothers. This authoritative reference delivers the most current data on medication safety during lactation, helping healthcare providers make informed clinical decisions with confidence. 

Extensively updated, the new edition synthesizes the latest research, clinical evidence, and real-world experience to evaluate drug transfer, infant exposure, and risk across more than 1,300 medications. Organized for rapid access and trusted worldwide, it equips clinicians with practical insight, including Lactation Risk Categories, detailed drug monographs, and guidance that supports both maternal health and breastfeeding outcomes. 

What’s New: 

• 75+ new drug monographs with clinical assessments even when milk data are limited  

• Expanded guidance on emerging therapies including monoclonal antibodies and GLP-1 agents  

• Enhanced clinical context integrating real-world data from InfantRisk Center consultations  

• New framework for decision-making linking maternal plasma levels to infant exposure  

Key Features: 

• Comprehensive coverage of over 1,300 medications, diseases, vaccines, and syndromes affecting breastfeeding safety 

• Make confident, evidence-based prescribing decisions for breastfeeding patients across a wide range of clinical scenarios 

• Practical clinical tools including LRC classifications, abbreviations, and quick-reference tables enhance usability 

• Led by Kaytlin Krutsch, Director of the InfantRisk Center, a recognized authority in lactational pharmacology and clinical research  

• Built on the legacy of Thomas W. Hale, whose pioneering work established the field’s most trusted reference resource